Lactobacillus rhamnosus KY-3 is a fermentative bacterium that is used for the industrial production of L-lactic acid. We have examined the effect of L. rhamnosus KY-3 and cellobiose as synbiotics on lipid metabolism in rats. Rats were fed on a 20% casein diet (C) supplemented with either 1.7% L, rhamnosus KY-3 (KY-3), 10% cellobiose (CEB), or 1.7%L. rhamnosus KY-3 and 10% cellobiose (KY-3 +CEB) for 13d. The concentrations of serum total lipids, triacylglycerol, total cholesterol, and phospholipids were significantly reduced in rats fed a KY-3+CEB diet in comparison to those on the C, KY-3 and CEB diets. There was an increase in the weight of cecal contents and a significant increase in the amount of cecal short-chain fatty acids (SCFA). The dry weight of excretion increased additively upon the simultaneous administration of L. rhamnosus KY-3 and cellobiose (KY-3+CEB). The amount of excreted fecal bile acids did not differ among the groups in this study. These findings sup port the hypothesis that the promotion of cecal fermentation can lower the level of serum lipids. These results suggest that simultaneous administration of L, rhamnosus KY-3 and cel lobiose as synbiotics has a beneficial effect on lipid metabolism.
Lactobacillus rhamnosus KY-3 was originally isolated from food mixture and is used in the industrial produc tion of L-lactic acid. We proposed a novel recycling sys tem for municipal food waste using L. rhamnosus KY-3 that combines fermentation and chemical processes to produce high quality poly-L-lactate biodegradable plas tics (1, 2) . L. rhamnosus KY-3 is formed as a by-product of the process and we have been examining the utiliza tion of this bacterium.
Investigations concerning the physiological function of the L, rhamnosus strain, represented by L. rhamnosus GG, found it promoted recovery from acute diarrhea caused by rotavirus (3, 4) , inhibited allergies (5, 6) , and improved fecal microflora and defecation (7, 8) . How ever, there has been no systematic study to examine the effect of L. rhamnosus on lipid metabolism. It has been reported that Lactobacillus species can act as probiotics, by lowering the level of blood cholesterol (9) (10) (11) . There fore, we anticipated that promoting the growth of L. rhamnosus KY-3 in the gut might have some effect on lipid metabolism. However, from our preliminary exam ination in the rat, a single administration of L. rhamno sus KY-3 had no detectable effect on lipid metabolism.
Prebiotics are defined as a 'non-digestible food ingre dient that beneficially affects the host by selectively stimulating the growth and/or activity of one or limited number of bacteria in the colon and thus improves host health' (12) . Due to the potential synergy between pro biotics and prebiotics, foods containing a combination of these ingredients are referred to as synbiotics (13) .
In this study, we evaluated whether simultaneous administration of L. rhamnosus KY-3, as a probiotic, with oligosaccharides, as a prebiotic, can exert a benefi cial effect on lipid metabolism. Cellobiose (14) was cho sen as the prebiotic, which was administered with assimilable oligosaccharides. The effect on lipid metabo lism of a single administration of cellobiose as a prebi otic has been reported by Satouchi et al. (15) . However, there are no reports of the effect of the cellobiose in administration with a probiotic. We found that the administration of cellobiose with L. rhamnosus KY-3 had a beneficial effect on lipid metabolism in rats. 
RESULTS
The results of body weight gain, food intake, food effi ciency, weight of liver and weight of adipose tissue are shown in Table 2 . None of these factors differed signifi cantly among any of the groups, although adipose tis sue weights of the epididymal and posterior abdominal wall were slightly reduced in rats fed on the KY-3+CEB diet as compared to rats fed on the C and KY-3 diets.
The concentration of serum total lipids was signifi cantly reduced in the KY-3+CEB group compared to the C group (Table 3) . However, no such reduction was observed for the rats fed the KY-3 or CEB diet. The same trend was also observed for triacylglycerol, total choles terol, and phospholipids. The results of the concentra tion of lipids in the liver are shown in Table 4 . The concentration of total lipids in rats fed the CEB or KY -3+CEB diet was significantly reduced compared to the control group fed the C diet. The concentration of tri acylglycerol was almost identical to that of total lipids. However, a slight reduction in the level of triacylglycerol Table 2 .
Effect of of KY-3 and cellobiose on body weight gain, food intake, food efficiency, and tissue weight in rats1.
1 Data are expressed as means and standard error (n=6). There was no significant difference (p<0.05) between data of each experimental groups, when analyzed by Duncan's multiple-range test. 2 Expressed as body weight gain per food intake . 2 Total expressed the sum of the three major short chain fatty acids (Acetate , Propionate, n-Butyrate). was observed for rats fed the KY -3 diet. There was no significant difference in liver choles terol among any of the groups studied. Rats fed the CEB diet had a reduced level of phospholipids. The weight, pH and amount of SCFA in the cecal content are shown in Table 5 . Cecal content weight in rats fed the CEB or KY-3+CEB diet were significantly increased compared to the control group (diet C). Interestingly, cecal content weight in rats fed the KY-3+CEB diet was significantly increased compared to the CEB diet. No corresponding increase was observed in rats fed the KY-3 diet.
The pH of the cecal contents was slightly lower for rats fed the KY-3+CEB diet. We also measured the level of each SCFA in the cecal contents. There was no signif icant difference in the level of butyric acid between the groups of rats. However, there was a significant increase in the level of acetic and propionic acid in rats fed CEB or KY-3+CEB diet, which considerably elevated the total amount of SCFA.
The property of the feces was normal. The dry weight of excrement in rats fed the KY-3, CEB or KY-3+CEB diet was significantly increased compared to the control group (C). This increase was most pronounced for rats fed the KY-3+CEB diet, being 1.7 and 1.6 times greater than the KY-3 group and CEB groups, respectively ( Table 6 ). The excretion of fecal bile acids did not differ among the groups. The excretion of cholesterol did not vary significantly between the groups, although there was a slight reduction in rats fed the KY-3+CEB diet. DISCUSSION Recently there have been numerous studies concern ing the use of lactic acid bacteria as probiotics. L. rham nosus GG, a representative strain of L. rhamnosus, has been studied in detail (3) (4) (5) (6) (7) (8) . We have examined the pos sibility of using L. rhamnosus KY-3, an L-lactic acid pro ducing bacterium, to improve lipid metabolism in rats. Preliminary experiments using a single administration of L. rhamnosus KY-3 had no significant effect on lipid metabolism.
In this study, we have also examined the simulta neous administration of KY-3 and cellobiose. It was anticipated that this simultaneous administration would promote the selective proliferation of probiotic bacteria and result in beneficial effects on lipid metabo lism.
Our results show that the simultaneous administra tion of L. rhamnosus KY-3 and cellobiose provokes a much stronger effect in reducing the serum lipid com pared to the single administration of bacterium. The single administration of cellobiose also showed some tendency to reduce the level of serum lipid, but this was less effective than cellobiose plus L. rhamnosus KY-3. The level of liver lipids was reduced regardless of the presence of L, rhamnosus KY-3. Satouchi et al. examined the effect of adding 1 to 2.5% of cellobiose on lipid metabolism in rats and reported reduced serum lipids and body fat (15) . Our results are in agreement with those of Satouchi et al, and show that cellobiose improves lipid metabolism in the serum and liver.
L. rhamnosus KY-3 significantly reduced serum lipids when administered simultaneously with cellobiose. We believe that the simultaneous administration of L. rhamnosus KY-3 with cellobiose is effective because of synbiotic utilization.
A number of mechanisms have been proposed for the observed lowering of the serum lipid concentration by lactic acid bacteria and indigestible oligosaccharides. These include the physiological action of metabolic products, cholesterol assimilation by intestinal micro flora, cholesterol binding to the bacterial cell wall, and enzymatic deconjugation of bile acid (22) (23) (24) (25) (26) . We have measured the levels of SCFA in the cecum, one of the end products of fermentation. Our results indicate the involvement of lipid metabolism, as demonstrated by the increased weight of cecal content and amount of total SCFA after simultaneous administration of L. rhamnosus KY-3 and cellobiose. The single administra tion of cellobiose showed a similar trend, suggesting that the increase in SCFA is involved in reducing the concentration of serum lipids.
Since intestinal microflora metabolize bile acids and act on various intestinal transformations (27) , they may exert effects on lipid metabolism including choles terols. A reduction in serum cholesterol may occur when bile acids get incorporated into Lactobacillus sp. and are then excreted with the cell (25) . The analysis of feces in this study showed no variation of bile acid excretion in the feces. However, there was a recogniz able increase in the amount of fecal excretion, espe cially after the simultaneous administration of L. rhamnosus KY-3 and cellobiose. However, it seems unlikely that the effect on the excretion of fecal bile acids, caused by L. rhamnosus KY-3, is the main mecha nism of reducing serum lipids. The excretion of choles terol tended to fall after the simultaneous admin istration of L. rhamnosus KY-3 and cellobiose. To eluci date the mechanism of action it is necessary to measure the levels of coprostanol, a neutral steroid component.
Due to the complex correlation between lipid levels and physiological variation of the host, several factors must be considered, including the effect of the prebiotic on the indigenous microflora. Preliminary examination using fluorescence in situ hybridization (FISH) analysis on rats fed the KY-3+CEB diet indicates an increased number of Lactobacillus in the cecal microflora and a decreased number of Escherichia coll. There was also an overall increase in the total number of bacteria in the cecum. The simultaneous administration of cellobiose and L, rhamnosus KY-3 increased the cecum content weight and level of SCFA. These findings support the hypothesis that promoting cecal fermentation and microbial variation can lower the level of serum lipids.
We are currently examining the optimal level and method of administering KY-3 and cellobiose to maxi mize the improvement in lipid metabolism.
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